Inventor · disambiguated record
Johannes Scheid
Also filed as: SCHEID JOHANNES
13 granted patents·4 pending applications·171 citations·filing 2010–2024
90Inventor score
Top patents by PatentIndex Score
17 records- 0196US9493549B2Antibodies directed toward the HIV-1 GP120 CD4 binding site with increased potency and breadthCALIFORNIA INST OF TECHN·Filed 2012·Granted Nov 15, 2016·55 cites·8 claims
- 0295US12071470B2Human immunodeficiency virus neutralizing antibodies and methods of use thereofUNIV ROCKEFELLER·Filed 2023·Granted Aug 27, 2024·2 cites·22 claims
- 0393US9783594B2Human immunodeficiency virus neutralizing antibodies and methods of use thereofSCHEID JOHANNES·Filed 2012·Granted Oct 10, 2017·48 cites·13 claims
- 0490US8673307B1HIV-1 anti-core neutralizing antibodies that target a conformational epitope within the ALPHA5-helix of GP120NUSSENZWEIG MICHEL C·Filed 2010·Granted Mar 18, 2014·53 cites·4 claims
- 0589US12428472B2Human immunodeficiency virus neutralizing antibodies and methods of use thereofUNIV ROCKEFELLER·Filed 2024·Granted Sep 30, 2025·0 cites·23 claims
- 0687US2024417449A1Highly active agonistic cd4 binding site anti-hiv antibodies (haads) comprising modified cdrh2 regions that improve contact with gp120CALIFORNIA INST OF TECHN·Filed 2024·Application pending·0 cites
- 0786US9890207B2Highly active agonistic CD4 binding site anti-HIV antibodies (HAADS) comprising modified CDRH2 regions that improve contact with GP120DISKIN RON·Filed 2012·Granted Feb 13, 2018·12 cites·10 claims
- 0885US2025115661A1Broadly neutralizing anti-hiv antibodies and epitope thereforUNIV ROCKEFELLER·Filed 2024·Application pending·0 cites
- 0983US12054538B2Highly active agonistic CD4 binding site anti-HIV antibodies (HAADS) comprising modified CDRH2 regions that improve contact with GP120CALIFORNIA INST OF TECHN·Filed 2022·Granted Aug 6, 2024·0 cites·3 claims
- 1077US10590187B2Highly active agonistic CD4 binding site anti-HIV antibodies (HAADS) comprising modified CDRH2 regions that improve contact with gp120CALIFORNIA INST OF TECHN·Filed 2017·Granted Mar 17, 2020·1 cites·5 claims
- 1176US11634478B2Human immunodeficiency virus neutralizing antibodies and methods of use thereofUNIV ROCKEFELLER·Filed 2021·Granted Apr 25, 2023·0 cites·17 claims
- 1272US11155605B2Nucleic acids encoding broadly neutralizing glycan-dependent 8ANC195 antibody variants that bind to an epitope spanning both HIV-1 ENV subunitsUNIV ROCKEFELLER·Filed 2019·Granted Oct 26, 2021·0 cites·11 claims
- 1372US2022002391A1Broadly Neutralizing Anti-HIV Antibodies and Epitope ThereforUNIV ROCKEFELLER·Filed 2021·Application pending·0 cites
- 1471US11472868B2Highly active agonistic CD4 binding site anti-HIV antibodies (HAADS) comprising modified CDRH2 regions that improve contact with GP120CALIFORNIA INST OF TECHN·Filed 2020·Granted Oct 18, 2022·0 cites·5 claims
- 1566US10889633B2Human immunodeficiency virus neutralizing antibodies and methods of use thereofUNIV ROCKEFELLER·Filed 2017·Granted Jan 12, 2021·0 cites·12 claims
- 1659US10421803B2Broadly neutralizing glycan-dependent 8ANC195 antibody variants that bind to an epitope spanning both HIV-1 Env subunitsUNIV ROCKEFELLER·Filed 2015·Granted Sep 24, 2019·0 cites·9 claims
- 1758US2024294613A1Cross-neutralizing sars-cov2 antibodiesBROAD INST INC·Filed 2021·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Johannes Scheid files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →